MAXIPIME (Hospira, Inc.)


Welcome to the PulseAid listing for the MAXIPIME drug offered from Hospira, Inc.. This Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: Cefepime
SUBSTANCE NAME: CEFEPIME HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-02-18
END MARKETING DATE: 0000-00-00


MAXIPIME HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMAXIPIME from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/1)
START MARKETING DATE: 2013-02-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-0217_e7b17358-ff09-4a0c-b94a-e08462dee95c
PRODUCT NDC: 0409-0217
APPLICATION NUMBER: NDA050679

Other CEFEPIME HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex Corp.Cefepime
B. Braun Medical Inc.CEFEPIME HYDROCHLORIDE AND DEXTROSE
Baxter Healthcare CorporationCefepime
Fresenius Kabi USA, LLCCefepime
Hospira, Inc.MAXIPIME
Qilu Pharmaceutical Co., Ltd.Cefepime
Sagent Pharmaceuticalscefepime
Sandoz IncCefepime Hydrochloride
WG Critical Care, LLCCefepime